Basic fibroblast growth factor (bFGF), heparin-binding EGF-like growth factor (HB-EGF) and vascular endothelial growth factor (VEGF) are heparin- binding growth factors that regulate endothelial cell (bFGF,VEGF) and smooth muscle cell (bFGF, HB-EGF) proliferation. They have been implicated in mediating tumor angiogenesis and smooth muscle cell hyperplasia in vivo. Recent studies have demonstrated that primary cultures of human T lymphocytes and tumor infiltrating lymphocytes synthesize bFGF and HB-EGF mRNA and export bFGF and HB-EGF-like growth factor activities. Synthesis of vascular cell growth factors by T cells may be significant since these cells infiltrate wounds, tumors and atherosclerotic plaques. The bFGF-like activity synthesized by T cells is atypical in that a substantial amount is exported suggesting that T cells produce an altered form of bFGF or have a novel mechanism of exporting bFGF. The affinity of bFGF, HB-EGF and VEGF for heparin is biologically significant since these growth factors need to interact with cell surface HSPG in order to bind to high affinity receptors and to have optimal mitogenic activity. The overall goals of the proposal are to investigate the structural and biological properties of these three heparin-binding vascular cell growth factors with an emphasis on, i) characterizing, purifying and cloning T cell growth factors and determining whether T cell bFGF is a novel member of the FGF family or has a novel mechanism of export, ii) analyzing the structural and biological mechanisms that mediate growth factor dependence on interactions with cell surface HSPG, and iii) analyzing VEGF, HB-EGF and bFGF expression and the significance thereof in tumors.
The SPECIFIC AIMS of this proposal are: (1). To characterize T Lymphocyte-derived bFGF- and HB-EGF-like cell growth factors in vitro and in vivo including a) purification, sequencing and cloning, b) analysis of possible mechanisms of T cell bFGF export, and c) analysis of their expression in T cells in tumors and vascular disease; (2). To analyze and compare the heparin-binding properties of bFGF, HB-EGF and VEGF including: a) analysis of the heparin-dependence of the mitogenic activity of these growth factors, b) identification of VEGF heparin-binding domains and comparing them to other heparin-binding domains, c) characterization and purification of a novel inducer of syndecan synthesis, a potential regulator of heparin-binding growth factor activity and d) expressing the heparinase 1 gene in mammalian cells as a novel method for ascertaining the role of HSPG in mediating growth factor activity; (3). To investigate VEGF and HB-EGF expression in prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA037392-14
Application #
2089323
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1983-01-01
Project End
1999-12-31
Budget Start
1995-03-01
Budget End
1995-12-31
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Mucka, Patrick; Levonyak, Nicholas; Geretti, Elena et al. (2016) Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency. Am J Pathol 186:2803-2812
Panigrahy, Dipak; Adini, Irit; Mamluk, Roni et al. (2014) Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration. Pathology 46:416-23
Akino, Tomoshige; Han, Xuezhe; Nakayama, Hironao et al. (2014) Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res 74:3716-26
Coma, Silvia; Allard-Ratick, Marc; Akino, Tomoshige et al. (2013) GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2. Angiogenesis 16:939-52
Snuderl, Matija; Batista, Ana; Kirkpatrick, Nathaniel D et al. (2013) Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell 152:1065-76
Buehler, Anima; Sitaras, Nicholas; Favret, Sandra et al. (2013) Semaphorin 3F forms an anti-angiogenic barrier in outer retina. FEBS Lett 587:1650-5
Shimizu, Akio; Nakayama, Hironao; Wang, Priscilla et al. (2013) Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. J Biol Chem 288:2210-22
Bielenberg, Diane R; Seth, Abhishek; Shimizu, Akio et al. (2012) Increased smooth muscle contractility in mice deficient for neuropilin 2. Am J Pathol 181:548-59
Wong, Hon-Kit; Shimizu, Akio; Kirkpatrick, Nathaniel D et al. (2012) Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism. Neoplasia 14:84-94
Coma, Silvia; Shimizu, Akio; Klagsbrun, Michael (2011) Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2. Cell Adh Migr 5:266-75

Showing the most recent 10 out of 112 publications